Advanced Ovarian Cancer and Chemotherapy
Links shared publicly online about this topic
Advanced ovarian cancer: Avastin-chemotherapy combination followed by Avastin alone improves PFS
buzzup.com — “Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study showed the combination of Avastin® (bevacizumab) and chemotherapy followed by maintenance use of Avastin alone increased the time women with previously untreated advanced ovarian cancer lived without the disease worsening (progression-free survival or PFS), compared to chemotherapy alone. A preliminary assessment of safety noted adverse events previously observed in pivotal trials of Avasti” View full resource at buzzup.com
Most Recently Shared on February 25, 2010 at 6:28 pm By:
Ovarian Cancer News: Advanced ovarian cancer: Avastin-chemotherapy combination followed by Avastin alone improv... http://buzzup.com/oyli_
Advanced ovarian cancer: Avastin-chemotherapy combination followed by Avastin alone improves PFS
news-medical.net — “Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study showed the combination of Avastin® (bevacizumab) and chemotherapy followed by maintenance use of Avastin alone increased the time women with previously untreated advanced ovarian cancer lived without the disease worsening (progression-free survival or PFS), compared to chemotherapy alone. A preliminary assessment of safety noted adverse events previously observed in pivotal trials of Avastin.” View full resource at news-medical.net
Most Recently Shared on February 25, 2010 at 10:40 am By:
Pregnancy News: Advanced ovarian cancer: Avastin-chemotherapy combination followed by Avastin alone improves PFS: ... http://bit.ly/aOjZqK
Neoadjuvant Chemotherapy for Advanced Ovarian Cancer - OrganizedWisdom Health
bit.ly — “: Dr. Maurie Markman reports on a study that indicates neoadjuvant chemotherapy followed by surgery is an acceptable alternative to primary surgery in patients with advanced ovarian cancer.” View full resource at bit.ly
Most Recently Shared on October 9, 2010 at 5:19 pm By:
Neoadjuvant Chemotherapy for Advanced Ovarian Cancer: : Dr. Maurie Markman reports on a study that indicates neoad... http://bit.ly/a4qOql
Dose-Dense Chemotherapy Improves Both Overall And Progression-Free Survival In Advanced Ovarian Cancer
medicalnewstoday.com — “Women given a more intensive 'dose-dense' regimen of chemotherapy survive longer and have a higher-rate of progression free survival, concludes an Article published Online First in an upcoming edi” View full resource at medicalnewstoday.com
Most Recently Shared on September 22, 2009 at 11:12 am By:
Dose-Dense Chemotherapy Improves Both Overall And Progression-Free Survival In Advanced Ovarian Cancer: Women gi.. http://bit.ly/RqyWW
Key advances in ovarian cancer (ASCO 2010 ) Video
vodpod.com — “Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Prof Ledermann discusses research demonstrating the effectiveness of combining bevacizumab with chemotherapy as first line treatment of ovarian cancer. A second key presentation was research indicating that PARP inhibitors are effective at treating not just ovarian cancer caused by BRCA mutation but also high grade serous cancer. If this result is confirmed in further studies, it wo” View full resource at vodpod.com
Most Recently Shared on July 22, 2010 at 9:59 pm By:
Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Pro… http://bit.ly/b7acun
How ovarian cancer resists chemotherapy
sciencedaily.com — “Researchers have zeroed in on a genetic process that may allow ovarian cancer to resist chemotherapy.” View full resource at sciencedaily.com
Most Recently Shared on March 2, 2011 at 10:27 pm By:
How ovarian cancer resists chemotherapy: Researchers have zeroed in on a genetic process that may allow ovarian ... http://bit.ly/ga9qW1
Review: Practical Considerations in Ovarian Cancer Chemotherapy - QualityPoint Technologies
qualitypointtech.net — “Intraperitoneal chemotherapy considerations are described for the treatment of epithelial ovarian cancer. Therapeutic Advances in Medical Oncology” View full resource at qualitypointtech.net
Most Recently Shared on August 9, 2010 at 10:15 am By:
Review: Practical Considerations in Ovarian Cancer Chemotherapy: Intraperitoneal chemotherapy considerations are d... http://bit.ly/9GX6Do
Oncology Article | ovarian cancer
mdlinx.com — “The Prognostic Impact of Duration of Anemia During Chemotherapy in Advanced Epithelial Ovarian Cancer” View full resource at mdlinx.com
Most Recently Shared on August 30, 2011 at 1:51 pm By:
The Prognostic Impact of Duration of Anemia During Chemotherapy in Advanced Epithelial Ovarian Cancer:... http://t.co/boXd8VR #oncology
Neoadjuvant chemotherapy in advanced ovarian cance... [Gynecol Oncol. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on October 1, 2010 at 1:24 pm By:
Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological... http://bit.ly/9Mqdk5
Treatment for Advanced Ovarian Cancer Effective
disabled-world.com — “New treatment regimen shown effective against advanced ovarian cancer” View full resource at disabled-world.com
Most Recently Shared on June 6, 2010 at 11:31 pm By:
Treatment for Advanced Ovarian Cancer Effective http://ff.im/-lA8Uw
New treatment regimen shown effective against advanced ovarian cancer
physorg.com — “Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival. Women receiving the new treatment ...” View full resource at physorg.com
Most Recently Shared on June 6, 2010 at 4:50 pm By:
New treatment regimen shown effective against advanced ovarian cancer http://tw.physorg.com/195047400
Bevacizumab extends progression-free survival in women with advanced ovarian cancer
news-medical.net — “Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival. Women receiving the new treatment regimen saw no worsening of their disease for 14.1 months, compared to 10.3 months for women receiving standard therapy.” View full resource at news-medical.net
Most Recently Shared on June 7, 2010 at 12:55 pm By:
Ovarian Cancer News: Bevacizumab extends progression-free survival in women with advanced ovarian cancer: Newly ... http://buzzup.com/zltp
Researchers uncovering how ovarian cancer resists chemotherapy
physorg.com — “York University researchers have zeroed in on a genetic process that may allow ovarian cancer to resist chemotherapy.” View full resource at physorg.com
Most Recently Shared on March 2, 2011 at 6:31 pm By:
Researchers uncovering how ovarian cancer resists chemotherapy http://bit.ly/hKInr4
New treatment regimen shown effective against advanced ovarian cancer
eurekalert.org — “Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival. Women receiving the new treatment regimen saw no worsening of their disease for 14.1 months, compared to 10.3 months for women receiving standard therapy.” View full resource at eurekalert.org
Most Recently Shared on June 6, 2010 at 6:53 pm By:
New treatment regimen shown effective against advanced ovarian cancer: (Fox Chase Cancer Center) Newly reported re... http://bit.ly/a8Fohc
Researchers investigate human reovirus with chemotherapy for ovarian cancer
news-medical.net — “Researchers are now investigating whether the human reovirus, when prescribed along with chemotherapy, will provide a desperately needed "one-two punch" against ovarian cancer.” View full resource at news-medical.net
Most Recently Shared on September 13, 2010 at 1:25 pm By:
Researchers investigate human reovirus with chemotherapy for ovarian cancer: Researchers are now investigating whe... http://bit.ly/bZC0iH
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest Ovarian Cancer news and research via News-Medical.Net
-
News-Medical.Net
Stay up to date with the latest Pregnancy news and research via News-Medical.Net
-
Ovarian Cancer OW
Organizing ovarian cancer resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement

